Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on the fence about investing in Integra LifeSciences Holdings Corporation, ICU Medical or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

Read on to learn how Integra LifeSciences Holdings Corporation, ICU Medical and Inc. compare based on key financial metrics to determine which better meets your investment needs.

About Integra LifeSciences Holdings Corporation, ICU Medical and Inc.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company’s customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

Latest Health Care Equipment & Supplies and Integra LifeSciences Holdings Corporation, ICU Medical, Inc. Stock News

As of September 1, 2026, Integra LifeSciences Holdings Corporation had a $1.3 billion market capitalization, compared to the Health Care Equipment & Supplies median of $405.9 million. Integra LifeSciences Holdings Corporation’s stock is NA in 2026, NA in the previous five trading days and up 9.85% in the past year.

Currently, Integra LifeSciences Holdings Corporation does not have a price-earnings ratio. Integra LifeSciences Holdings Corporation’s trailing 12-month revenue is $1.6 billion with a -0.4% net profit margin. Year-over-year quarterly sales growth most recently was 0.8%. Analysts expect adjusted earnings to reach $2.457 per share for the current fiscal year. Integra LifeSciences Holdings Corporation does not currently pay a dividend.

Currently, ICU Medical, Inc.’s price-earnings ratio is 141.9. ICU Medical, Inc.’s trailing 12-month revenue is $2.2 billion with a 1.4% net profit margin. Year-over-year quarterly sales growth most recently was 0.5%. Analysts expect adjusted earnings to reach $8.753 per share for the current fiscal year. ICU Medical, Inc. does not currently pay a dividend.

How We Compare Integra LifeSciences Holdings Corporation, ICU Medical and Inc. Stock Grades

Stock evaluation requires access to huge amounts of data and the knowledge and time to sift through it all, make sense of financial ratios, read income statements and analyze recent stock movements. AAII created A+ Investor, a robust data suite that condenses data research in an actionable and customizable way suitable for investors of all knowledge levels, to help investors streamline and work through such data.

AAII’s proprietary stock grades come with A+ Investor. These offer intuitive A‐F grades for each of five key investing factors: value, growth, momentum, earnings estimate revisions and quality. Here, we’ll take a closer look at Integra LifeSciences Holdings Corporation, ICU Medical and Inc.’s stock grades to see how they measure up against one another.

Learn more about A+ Investor here!

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

Integra LifeSciences Holdings Corporation, ICU Medical and Inc. Growth Grades

Company	Ticker	Growth
Integra LifeSciences Holdings Corporation	IART	B
ICU Medical, Inc.	ICUI	D

The foundation of growth investing is seeking out stocks of companies exhibiting strong, consistent and prolonged growth that is expected to continue into the future.

In order to compute the growth score and assign it a letter grade, the percentile ranks for each of three components‐consistency of annual sales growth, five-year sales growth rankings adjusted for extreme levels, and consistency of positive annual cash from operations‐must be determined. These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s Growth Score to create an equal distribution of grades.

The companies in the bottom 20% of the stock universe receive Growth Grades of F, considered to be very weak, while those in the top 20% receive A grades, which are considered very strong.

Integra LifeSciences Holdings Corporation has a Growth Score of 73, which is Strong. ICU Medical, Inc. has a Growth Score of 38, which is Weak.

The Growth Grade Winner: Integra LifeSciences Holdings Corporation

As you can clearly see from the Growth Grade breakdown above, Integra LifeSciences Holdings Corporation has a more attractive growth grade than ICU Medical, Inc.. For investors who focus solely on how a company is growing relative to other companies in the same industry, Integra LifeSciences Holdings Corporation could be a good stock to add to their portfolio. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Integra LifeSciences Holdings Corporation, ICU Medical and Inc.’s Quality Grades

Company	Ticker	Quality
Integra LifeSciences Holdings Corporation	IART	C
ICU Medical, Inc.	ICUI	B

Like the Value Grade, AAII’s A+ Investor Quality Grade comes from the percentile rank of key metrics. Specifically, the Quality Score is the percentile rank of the average of the percentile ranks of return on assets (ROA), return on invested capital (ROIC), gross profit relative to assets, buyback yield, change in total liabilities to assets, accruals, Z double prime bankruptcy risk (Z) score and the F-Score.

The score is variable, meaning it can consider all eight measures or, should any of the eight measures not be valid, the remaining measures that are valid. To be assigned a Quality Score, stocks must have a valid (non-null) measure and corresponding ranking for at least four of the eight quality measures.

The Quality Score is used to assess the underlying “quality” of a particular stock. A higher-quality stock possesses traits associated with upside potential and reduced downside risk. Backtesting of the Quality Grade shows that stocks with higher grades, on average, outperformed stocks with lower grades over the period of 1998 through 2019.

Stocks receive better grades (higher scores) for having higher scores for the quality subcomponents and worse grades (lower scores) for lower scores for the subcomponents.

Integra LifeSciences Holdings Corporation has a Quality Score of 59, which is Average. ICU Medical, Inc. has a Quality Score of 67, which is Strong.

The Quality Grade Winner: ICU Medical, Inc.

As you can clearly see from the Quality Grade breakdown above, ICU Medical, Inc. has a better overall quality grade than Integra LifeSciences Holdings Corporation. For investors who are looking for companies with higher quality than others in the same industry, ICU Medical, Inc. could be a good stock to add to their portfolios. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Integra LifeSciences Holdings Corporation, ICU Medical and Inc.’s Momentum Grades

Company	Ticker	Momentum
Integra LifeSciences Holdings Corporation	IART	C
ICU Medical, Inc.	ICUI	A

Momentum grades help to uncover stocks experiencing anomalously high rates of return; research finds that stocks with high relative levels of momentum tend to outperform, whereas those with low levels of momentum tend to continue underperforming. Momentum is based on the price change of a stock over a specified period relative to all other stocks.

Typically, AAII looks at the weighted relative strength over the trailing four quarters. The weighted four-quarter relative strength rank is the relative price change for each of the past four quarters. The most recent quarterly price change is given a weight of 40% and each of the three previous quarters are given a weighting of 20%.

Integra LifeSciences Holdings Corporation has a Momentum Score of 56, which is Average. ICU Medical, Inc. has a Momentum Score of 81, which is Very Strong.

The Momentum Grade Winner: ICU Medical, Inc.

As you can clearly see from the Momentum Grade breakdown above, ICU Medical, Inc. is considered to have stronger momentum compared to Integra LifeSciences Holdings Corporation. For those specifically looking for companies that have stronger momentum compared to other companies in the same industry, ICU Medical, Inc. could be a good stock to invest in. However, it’s important for investors to analyze multiple factors based on a wide range of metrics before deciding whether to buy.

Other Integra LifeSciences Holdings Corporation, ICU Medical and Inc. Grades

In addition to Quality, Momentum and Growth, A+ Investor also provides grades for Value and Estimate Revisions.

Earnings estimate revisions scores take into account the magnitude of a company’s earnings surprise in its last two reported fiscal quarters. Often, surprises beget further surprises‐or at least continued sales growth (the exact opposite is generally true, too).

Successful stock investing involves buying low and selling high, so stock valuation is an important consideration for stock selection. Buying stocks that are going to go up typically means buying stocks that are undervalued in the first place, although momentum investors may argue that point.

These 2 key factors, when combined with the above, provide a holistic view into a particular stock. Further, by joining A+ Investor you can see whether Integra LifeSciences Holdings Corporation, ICU Medical and Inc. pass any of our 60+ stock screens that have outperformed the market since their creation.

So, Which Is the Better Investment, Integra LifeSciences Holdings Corporation, ICU Medical or Inc. Stock?

Overall, Integra LifeSciences Holdings Corporation stock has a Growth Score of 73, Momentum Score of 56 and Quality Score of 59.

ICU Medical, Inc. stock has a Growth Score of 38, Momentum Score of 81 and Quality Score of 67.

Comparing Integra LifeSciences Holdings Corporation, ICU Medical and Inc.’s grades, scores and metrics can act as a solid basis to determine whether they may be a good investment or not. You’ll also want to look at your portfolio’s asset allocation as well as your risk tolerance and financial goals to see if either of these stocks would make a good fit for you. AAII can help you figure out which investments align with your individual needs and preferences.

Investors are encouraged to do their own due diligence and research. In this way, individuals can effectively become managers of their own assets‐without having to rely on others for financial independence. You can count on AAII for timeless articles on financial planning and stock-picking, unbiased research and actionable analysis.

A+ Investor adds to our qualitative teaching with a powerful data suite to help you whittle down investment choices to find stocks, exchange-traded funds (ETFs) or mutual funds that meet your needs.

AAII Disclaimer

We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown, because past, hypothetical or simulated performance is not necessarily indicative of future results. Before making an investment decision, you should consider your circumstances and whether the information on our content is applicable to your situation. This information was prepared in good faith, and we accept no liability for any errors or omissions. The full disclaimer can be read here.